Agonist/Antagonist Analgesics
Tomoji Yanagita
Abstract
Open-access reader
Tomoji Yanagita
Abstract
Open-access reader
Pentazocine (PZ), buprenorphine, butorphanol, cyclazocine, and nalbuphine are known to have opioid agonistic and opiate antagonistic effects. The analgesic efficacies of these drugs are generally high, and the relative potencies against morphine in humans are, in the above order, 1/3, 20-40, 5, 10-20, 1, and 1/7-1/10. The relative potencies of the antagonistic effect against nalorphine in humans are 1/50, 10, none, 5-7, 1, and 1/7-1/10 respectively. However, both in animals and humans, the synergism between morphine and PZ is observable when the doses of both drugs are relatively low.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Pentazocine (PZ), buprenorphine, butorphanol, cyclazocine, and nalbuphine are known to have opioid agonistic and opiate antagonistic effects. The analgesic efficacies of these drugs are generally high, and the relative potencies against morphine in humans are, in the above order, 1/3, 20-40, 5, 10-20, 1, and 1/7-1/10. The relative potencies of the antagonistic effect against nalorphine in humans are 1/50, 10, none, 5-7, 1, and 1/7-1/10 respectively. However, both in animals and humans, the synergism between morphine and PZ is observable when the doses of both drugs are relatively low.
Key concepts: Nalbuphine, Nalorphine, Pentazocine, Butorphanol, Morphine, Pharmacology, Buprenorphine, Analgesic